# Chondroitin Sulfate for Crohn's Disease

> **NCT01245088** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **University Hospitals Cleveland Medical Center**

## Conditions studied

- Crohn's Disease

## Interventions

- **DRUG:** chondroitin sulfate

## Key facts

- **NCT ID:** NCT01245088
- **Lead sponsor:** University Hospitals Cleveland Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-01
- **Primary completion:** 2012-03
- **Final completion:** 2012-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor withdrew support after no patients enrolled
- **Last updated:** 2012-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01245088

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01245088, "Chondroitin Sulfate for Crohn's Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01245088. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*